AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by AC Immune SA for the month of November 2017. The filing was submitted on November 2, 2017, and is signed by CEO Andrea Pfeifer and CFO Joerg Hornstein. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a cover sheet referencing an external press release rather than containing detailed financial statements.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period. The content is limited to the submission of a press release dated November 2, 2017 (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumably contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.
Key Facts for Investor Verification
- Verify the content of the press release dated November 2, 2017 (Exhibit 99.1) referenced in this filing.
- Confirm the specific corporate announcement or event triggering this Form 6-K submission.
- Review the company's most recent Form 20-F for detailed financial data, as this filing does not include financial metrics.